These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38722111)

  • 1.
    Daungsupawong H; Wiwanitkit V
    Photobiomodul Photomed Laser Surg; 2024 Jun; 42(6):437. PubMed ID: 38722111
    [No Abstract]   [Full Text] [Related]  

  • 2. Photobiomodulation in the Treatment of Dysgeusia in Patients with Long COVID: A Single-Blind, Randomized Controlled Trial.
    Fontana CE; Parreira L; Pinheiro S
    Photobiomodul Photomed Laser Surg; 2024 Jun; 42(6):438. PubMed ID: 38888186
    [No Abstract]   [Full Text] [Related]  

  • 3. Photobiomodulation in the Treatment of Dysgeusia in Patients with Long COVID: A Single-Blind, Randomized Controlled Trial.
    Parreira LFS; Pinheiro SL; Fontana CE
    Photobiomodul Photomed Laser Surg; 2024 Mar; 42(3):215-224. PubMed ID: 38416635
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.
    Krishnakumar HN; Momtaz DA; Sherwani A; Mhapankar A; Gonuguntla RK; Maleki A; Abbas A; Ghali AN; Al Afif A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):505-509. PubMed ID: 36209486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
    Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
    Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia?
    Sarode GS; Sarode SC; Gadbail AR; Gondivkar S; Sharma NK; Patil S
    Med Hypotheses; 2021 Jan; 146():110413. PubMed ID: 33261916
    [No Abstract]   [Full Text] [Related]  

  • 7. Photobiomodulation therapy for treatment olfactory and taste dysfunction COVID-19-related: A case report.
    de Souza VB; Ferreira LT; Sene-Fiorese M; Garcia V; Rodrigues TZ; de Aquino Junior AE; Bagnato VS; Panhoca VH
    J Biophotonics; 2022 Aug; 15(8):e202200058. PubMed ID: 35445797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xerostomia and COVID-19: Unleashing Pandora's Box.
    Saniasiaya J
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):139S. PubMed ID: 32955342
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased Prevalence of Dysgeusia in Pediatric Patients Diagnosed with COVID-19.
    Katz J; Guelmann M
    Pediatr Dent; 2021 Jul; 43(4):282-284. PubMed ID: 34467844
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanisms and Management of COVID-19-Associated Taste Disorders].
    Zheng X; Xu X; Zhou XD; Peng X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):334-341. PubMed ID: 36949695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Role of Photobiomodulation in Long COVID-19 Patients Rehabilitation.
    Fekrazad R; Fekrazad S
    Photobiomodul Photomed Laser Surg; 2021 Apr; 39(4):229-231. PubMed ID: 33497594
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintaining Photobiomodulation Research During the COVID-19 Pandemic.
    Laakso EL; Ralph M
    Photobiomodul Photomed Laser Surg; 2021 Sep; 39(9):579-580. PubMed ID: 34468205
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysgeusia: A review in the context of COVID-19.
    Thomas DC; Chablani D; Parekh S; Pichammal RC; Shanmugasundaram K; Pitchumani PK
    J Am Dent Assoc; 2022 Mar; 153(3):251-264. PubMed ID: 34799014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal photobiomodulation therapy for COVID-19-related olfactory dysfunction: A Brazilian multicenter case series.
    Soares LES; Guirado MMG; Berlingieri G; Ramires MCCH; Lyra LAOP; Teixeira IS; Oliveira PC; Tateno RY; Palma LF; Campos L
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102574. PubMed ID: 34628071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?
    Alharbi H; You S; Katz J
    Oral Maxillofac Surg; 2022 Mar; 26(1):105-111. PubMed ID: 33954852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
    Baig AM; Sanders EC
    ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral manifestations of COVID-19 in unvaccinated patients: a cross-sectional study.
    Fernandes TJ; Ogrzewalska M; Martins EB; de Siqueira MAMT; Brasil P; Calvet GA
    BMC Oral Health; 2023 Sep; 23(1):696. PubMed ID: 37759210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminatory Value of Self-reported Olfactory Dysfunction in the Prediction of Coronavirus Disease 2019.
    Akaishi T; Kushimoto S; Katori Y; Kure S; Igarashi K; Fujita M; Takayama S; Abe M; Kikuchi A; Tanaka J; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
    Intern Med; 2021 Sep; 60(18):2905-2910. PubMed ID: 34248118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis.
    Mutiawati E; Fahriani M; Mamada SS; Fajar JK; Frediansyah A; Maliga HA; Ilmawan M; Emran TB; Ophinni Y; Ichsan I; Musadir N; Rabaan AA; Dhama K; Syahrul S; Nainu F; Harapan H
    F1000Res; 2021; 10():40. PubMed ID: 33824716
    [No Abstract]   [Full Text] [Related]  

  • 20. Blue photobiomodulation LED therapy impacts SARS-CoV-2 by limiting its replication in Vero cells.
    Zupin L; Gratton R; Fontana F; Clemente L; Pascolo L; Ruscio M; Crovella S
    J Biophotonics; 2021 Apr; 14(4):e202000496. PubMed ID: 33619888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.